Routine first-line detection of breast cancer therapy-related cardiotoxicity by serial, fast and ultra-low-dose equilibrium radionuclide angiography.
Fiche publication
Date publication
octobre 2022
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARIE Pierre-Yves, Dr CLAUDIN Marine, Dr LAMBERT Aurélien
Tous les auteurs :
Decorads CE, Lambert A, Roch V, Imbert L, Perrin M, Claudin M, Salleron J, Veran N, Lamiral Z, Henneton C, Marie PY
Lien Pubmed
Résumé
This study assesses a first-line left ventricular ejection fraction (LVEF) monitoring provided by an ultra-low-dose equilibrium radionuclide angiography (ERNA) in breast cancer women treated with potentially cardiotoxic drugs and analyzes patient outcome based on the ERNA results.
Mots clés
breast cancer, cardiotoxicity, chemotherapy, equilibrium radionuclide angiography, ionizing radiations
Référence
J Nucl Cardiol. 2022 10 26;: